|Diabetes and Osteoporosis|
LLLT and The Treatment of Periodontal Disease in
Diabetes and Osteoporosis
Rozalia Dana Vieru1, Lewis Clayman2, Anca Dumitriu3
1, 3: Department of Periodontology, Faculty of Dentistry, Carol Davila Medical and Pharmaceutical University, Bucharest, Romania; 1: New York School for Medical and Dental Assistants, New York, USA; 2: Clinical Prof. OMS, University of Michigan,
The objective of this study is to demonstrate whether the application of low level laser therapy (LLLT), for osteoporotic patients and diabetic patients, in addition to standard procedures employed to treat periodontal disease, improves the outcome of the treatment. Diabetic individuals are three times more likely to have attachment and bone loss than non-diabetic patients. Furthermore, osteoporosis is always associated with alveolar bone loss. Women with osteoporosis have increased alveolar bone retraction, attachment loss, and tooth loss compared with women without osteoporosis. Estrogen deficiency has been linked to decreases in alveolar bone. Approximately half of the diabetic patients and half of the patients with osteoporosis received LLLT in addition to the classic treatment. In this study we searched for the effects of LLLT on advanced chronic periodontal diseases that had caused severe destruction of the periodontal structures and increased tooth mobility. For all four groups (1) diabetic patients treated with LLLT; (2) diabetic patients without LLLT; (3) osteoporotic patients treated with LLLT; and (4) osteoporotic patients without LLLT) we determined the mean and standard deviations of the following parameters: gingival bleeding time, pain relief time, bone recovery time. The diabetic patients treated with LLLT proved to have a more immediate response and osteoporotic patients showed better response over the long term. All the LLLT-treated groups were superior to the non-treated control groups in both the diabetic and osteoporotic patients.
The general social benefits are the development of a novel LLLT modality for treatment of periodontal disease, which allows for early noninvasive treatment of periodontal infection.